Paul A. Gardner, MDAssistant Professor of Neurological Surgery
Co-Director, Center for Skull Base Surgery
Paul A. Gardner, MD, joined the faculty at the University of Pittsburgh Department of Neurological Surgery in 2008 after completing his residency and fellowship training at the University of Pittsburgh. He completed his undergraduate studies at Florida State University, majoring in biochemistry, and received his medical degree from the University of Pittsburgh School of Medicine.
Dr. Gardner completed a two-year fellowship with Amin Kassam, MD, in endoscopic endonasal pituitary and endoscopic and open skull base surgery. His research has focused on evaluating patient outcomes following these surgeries. In April of 2008, Dr. Gardner was named co-director of the Center for Minimally Invasive Cranial Base Surgery at the University of Pittsburgh Medical Center. Dr. Gardner is a native of Niceville, FL.
Dr. Gardner's publications can be reviewed through the National Library of Medicine's publication database.
Children’s Hospital of Pittsburgh of UPMC
Veterans Affairs Pittsburgh Healthcare System
Professional Organization Membership
Alpha Omega Alpha Honor Society
American Association of Neurological Surgeons
Congress of Neurological Surgeons
North American Skull Base Society
Pioneering Surgery Saves 5-Year-Old's Life
December 16, 2009
KDKA-TV Evening News
Rare surgery to restore Jain Acharya's eyesight
March 6, 2009
A million well-wishers, 15 doctors point guru to Pittsburgh
February 12, 2009
Research activities for Paul Gardner, MD, center around skull base tumors, exploring clinical outcomes of surgical approaches and management and molecular analysis to better predict outcomes and model future treatments. In addition to other smaller reports and series, outcomes of large series of tumors such as pituitary adenomas, chordomas, angiofibromas and cranopharyngiomas are currently in press. A prospective, randomized trial to evaluate the usage of lumbar drains following endoscopic endonasal skull base surgery has nearly reached its midpoint. An analysis of chordoma molecular markers via exomix sequencing with a goal of applying next-generation sequencing techniques to clival chordomas in order to better understand the genetic alterations that confer pathogenicity. A better understanding of the molecular characteristics of chordoma might lead to new strategies for their treatment.